Showing results (861-870 of 1,231) with videos related to

Sort By:
Pageof 124
Ophthalmology|October 15, 2013
Prediction of age-related macular degeneration in the general population: the Three Continent AMD ConsortiumGabriëlle H S Buitendijk, Elena Rochtchina, Chelsea Myers, et al.
Haematologica|September 24, 2016
Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromesEline M P Cremers, Theresia M Westers, Canan Alhan, et al.
Oncotarget|October 20, 2018
Lenalidomide combined with low-dose cyclophosphamide and prednisone modulates Ikaros and Aiolos in lymphocytes, resulting in immunostimulatory effects in lenalidomide-refractory multiple myeloma patientsLaurens E Franssen, Inger S Nijhof, Chad C Bjorklund, et al.
Blood|September 21, 2016
Phase 1/2 study of lenalidomide combined with low-dose cyclophosphamide and prednisone in lenalidomide-refractory multiple myelomaInger S Nijhof, Laurens E Franssen, Mark-David Levin, et al.
American Journal of Hematology|June 6, 2015
Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohortAndrew M Evens, Jennifer A Kanakry, Laurie H Sehn, et al.
Human Molecular Genetics|July 1, 2005
Meta-analysis of genome scans of age-related macular degenerationSheila A Fisher, Goncalo R Abecasis, Beverly M Yashar, et al.
Diabetologia|June 18, 2014
GWAS identifies an NAT2 acetylator status tag single nucleotide polymorphism to be a major locus for skin fluorescenceKaren M Eny, Helen L Lutgers, John Maynard, et al.
Leukemia|July 22, 2022
Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndromeJ J W M Janssen, B Löwenberg, M Manz, et al.
Blood Advances|September 11, 2020
Ibrutinib added to 10-day decitabine for older patients with AML and higher risk MDSGerwin Huls, Dana A Chitu, Thomas Pabst, et al.
Hemasphere|May 8, 2023
NK Cell Phenotype Is Associated With Response and Resistance to Daratumumab in Relapsed/Refractory Multiple MyelomaChristie P M Verkleij, Kristine A Frerichs, Marloes E C Broekmans, et al.
Pageof 124